314 related articles for article (PubMed ID: 29303221)
1. The use of sonographic subjective tumor assessment, IOTA logistic regression model 1, IOTA Simple Rules and GI-RADS system in the preoperative prediction of malignancy in women with adnexal masses.
Koneczny J; Czekierdowski A; Florczak M; Poziemski P; Stachowicz N; Borowski D
Ginekol Pol; 2017; 88(12):647-653. PubMed ID: 29303221
[TBL] [Abstract][Full Text] [Related]
2. Lesion size affects diagnostic performance of IOTA logistic regression models, IOTA simple rules and risk of malignancy index in discriminating between benign and malignant adnexal masses.
Di Legge A; Testa AC; Ameye L; Van Calster B; Lissoni AA; Leone FP; Savelli L; Franchi D; Czekierdowski A; Trio D; Van Holsbeke C; Ferrazzi E; Scambia G; Timmerman D; Valentin L
Ultrasound Obstet Gynecol; 2012 Sep; 40(3):345-54. PubMed ID: 22611001
[TBL] [Abstract][Full Text] [Related]
3. Performance of IOTA Simple Rules, Simple Rules risk assessment, ADNEX model and O-RADS in differentiating between benign and malignant adnexal lesions in North American women.
Hiett AK; Sonek JD; Guy M; Reid TJ
Ultrasound Obstet Gynecol; 2022 May; 59(5):668-676. PubMed ID: 34533862
[TBL] [Abstract][Full Text] [Related]
4. Adnexal masses difficult to classify as benign or malignant using subjective assessment of gray-scale and Doppler ultrasound findings: logistic regression models do not help.
Valentin L; Ameye L; Savelli L; Fruscio R; Leone FP; Czekierdowski A; Lissoni AA; Fischerova D; Guerriero S; Van Holsbeke C; Van Huffel S; Timmerman D
Ultrasound Obstet Gynecol; 2011 Oct; 38(4):456-65. PubMed ID: 21520475
[TBL] [Abstract][Full Text] [Related]
5. Accuracy of IOTA Simple Rules, IOTA ADNEX Model, RMI, and Subjective Assessment for Preoperative Adnexal Mass Evaluation: The Experience of a Tertiary Care Referral Hospital.
Vilendecic Z; Radojevic M; Stefanovic K; Dotlic J; Likic Ladjevic I; Dugalic S; Stefanovic A
Gynecol Obstet Invest; 2023; 88(2):116-122. PubMed ID: 36716716
[TBL] [Abstract][Full Text] [Related]
6. Prospective evaluation of IOTA logistic regression models LR1 and LR2 in comparison with subjective pattern recognition for diagnosis of ovarian cancer in an outpatient setting.
Nunes N; Ambler G; Foo X; Widschwendter M; Jurkovic D
Ultrasound Obstet Gynecol; 2018 Jun; 51(6):829-835. PubMed ID: 28976616
[TBL] [Abstract][Full Text] [Related]
7. Subjective assessment versus ultrasound models to diagnose ovarian cancer: A systematic review and meta-analysis.
Meys EM; Kaijser J; Kruitwagen RF; Slangen BF; Van Calster B; Aertgeerts B; Verbakel JY; Timmerman D; Van Gorp T
Eur J Cancer; 2016 May; 58():17-29. PubMed ID: 26922169
[TBL] [Abstract][Full Text] [Related]
8. Ovarian cancer prediction in adnexal masses using ultrasound-based logistic regression models: a temporal and external validation study by the IOTA group.
Timmerman D; Van Calster B; Testa AC; Guerriero S; Fischerova D; Lissoni AA; Van Holsbeke C; Fruscio R; Czekierdowski A; Jurkovic D; Savelli L; Vergote I; Bourne T; Van Huffel S; Valentin L
Ultrasound Obstet Gynecol; 2010 Aug; 36(2):226-34. PubMed ID: 20455203
[TBL] [Abstract][Full Text] [Related]
9. Prospective external validation of IOTA methods for classifying adnexal masses and retrospective assessment of two-step strategy using benign descriptors and ADNEX: a Portuguese multicenter study.
Borges AL; Brito M; Ambrósio P; Condeço R; Pinto P; Ambrósio B; Mahomed F; Gama JMR; Bernardo MJ; Gouveia AI; Djokovic D
Ultrasound Obstet Gynecol; 2024 Mar; ():. PubMed ID: 38477149
[TBL] [Abstract][Full Text] [Related]
10. Improving strategies for diagnosing ovarian cancer: a summary of the International Ovarian Tumor Analysis (IOTA) studies.
Kaijser J; Bourne T; Valentin L; Sayasneh A; Van Holsbeke C; Vergote I; Testa AC; Franchi D; Van Calster B; Timmerman D
Ultrasound Obstet Gynecol; 2013 Jan; 41(1):9-20. PubMed ID: 23065859
[TBL] [Abstract][Full Text] [Related]
11. Improving the preoperative classification of adnexal masses as benign or malignant by second-stage tests.
Daemen A; Valentin L; Fruscio R; Van Holsbeke C; Melis GB; Guerriero S; Czekierdowski A; Jurkovic D; Ombelet W; Rossi A; Vergote I; Bourne T; De Moor B; Timmerman D
Ultrasound Obstet Gynecol; 2011 Jan; 37(1):100-6. PubMed ID: 20814878
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic performance of IOTA SR and O-RADS combined with CA125, HE4, and risk of malignancy algorithm to distinguish benign and malignant adnexal masses.
Yang Y; Ju H; Huang Y
Eur J Radiol; 2023 Aug; 165():110926. PubMed ID: 37418798
[TBL] [Abstract][Full Text] [Related]
13. Estimating risk of malignancy in adnexal masses: external validation of the ADNEX model and comparison with other frequently used ultrasound methods.
Meys EMJ; Jeelof LS; Achten NMJ; Slangen BFM; Lambrechts S; Kruitwagen RFPM; Van Gorp T
Ultrasound Obstet Gynecol; 2017 Jun; 49(6):784-792. PubMed ID: 27514486
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of IOTA simple rules, O-RADS, and CA125 to distinguish benign and malignant adnexal masses.
Xie WT; Wang YQ; Xiang ZS; Du ZS; Huang SX; Chen YJ; Tang LN
J Ovarian Res; 2022 Jan; 15(1):15. PubMed ID: 35067220
[TBL] [Abstract][Full Text] [Related]
15. Intra- and interobserver agreement when describing adnexal masses using the International Ovarian Tumor Analysis terms and definitions: a study on three-dimensional ultrasound volumes.
Sladkevicius P; Valentin L
Ultrasound Obstet Gynecol; 2013 Mar; 41(3):318-27. PubMed ID: 22915506
[TBL] [Abstract][Full Text] [Related]
16. Comparison of O-RADS, GI-RADS, and IOTA simple rules regarding malignancy rate, validity, and reliability for diagnosis of adnexal masses.
Basha MAA; Metwally MI; Gamil SA; Khater HM; Aly SA; El Sammak AA; Zaitoun MMA; Khattab EM; Azmy TM; Alayouty NA; Mohey N; Almassry HN; Yousef HY; Ibrahim SA; Mohamed EA; Mohamed AEM; Afifi AHM; Harb OA; Algazzar HY
Eur Radiol; 2021 Feb; 31(2):674-684. PubMed ID: 32809166
[TBL] [Abstract][Full Text] [Related]
17. Prospective external validation of IOTA three-step strategy for characterizing and classifying adnexal masses and retrospective assessment of alternative two-step strategy using simple-rules risk.
Hidalgo JJ; Ros F; Aubá M; Errasti T; Olartecoechea B; Ruiz-Zambrana Á; Alcázar JL
Ultrasound Obstet Gynecol; 2019 May; 53(5):693-700. PubMed ID: 30353585
[TBL] [Abstract][Full Text] [Related]
18. Prospective comparative trial comparing O-RADS, IOTA ADNEX model, and RMI score for preoperative evaluation of adnexal masses for prediction of ovarian cancer.
Poonyakanok V; Tanmahasamut P; Jaishuen A
J Obstet Gynaecol Res; 2023 May; 49(5):1412-1417. PubMed ID: 36895122
[TBL] [Abstract][Full Text] [Related]
19. Predicting the risk of malignancy in adnexal masses based on the Simple Rules from the International Ovarian Tumor Analysis group.
Timmerman D; Van Calster B; Testa A; Savelli L; Fischerova D; Froyman W; Wynants L; Van Holsbeke C; Epstein E; Franchi D; Kaijser J; Czekierdowski A; Guerriero S; Fruscio R; Leone FPG; Rossi A; Landolfo C; Vergote I; Bourne T; Valentin L
Am J Obstet Gynecol; 2016 Apr; 214(4):424-437. PubMed ID: 26800772
[TBL] [Abstract][Full Text] [Related]
20. Multicentre external validation of IOTA prediction models and RMI by operators with varied training.
Sayasneh A; Wynants L; Preisler J; Kaijser J; Johnson S; Stalder C; Husicka R; Abdallah Y; Raslan F; Drought A; Smith AA; Ghaem-Maghami S; Epstein E; Van Calster B; Timmerman D; Bourne T
Br J Cancer; 2013 Jun; 108(12):2448-54. PubMed ID: 23674083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
